Rare diseases

Explore drug discovery landscapes

Rare neurological diseases

Motor neuron disease

Congenital diaphragmatic hernia

Charcot-Marie-Tooth disease type 1

CLN3 disease

Myotonic dystrophy

Spinocerebellar ataxia type 3

Congenital muscular dystrophy

Myotonic syndrome

Rett syndrome

Narcolepsy

Neuromyelitis optica spectrum disorder

Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy

Angelman syndrome

Multiple system atrophy

Frontotemporal dementia

Becker muscular dystrophy

MELAS

Hereditary spastic paraplegia

Behavioral variant of frontotemporal dementia

Oculopharyngeal muscular dystrophy

Pelizaeus-Merzbacher disease

Spinocerebellar ataxia type 1

Friedreich ataxia

Facioscapulohumeral dystrophy

Mitochondrial myopathy

Steinert myotonic dystrophy

NMDA receptor encephalitis

Duchenne and Becker muscular dystrophy

Charcot-Marie-Tooth disease type 1A

CLN2 disease

Aicardi-Goutières syndrome

Laminin subunit alpha 2-related congenital muscular dystrophy

Autosomal dominant cerebellar ataxia

Corticobasal syndrome

Dysferlin-related limb-girdle muscular dystrophy R2

Spinocerebellar ataxia type 7

Spinocerebellar ataxia type 2

Collagen VI-related congenital muscular dystrophy

Lennox-Gastaut syndrome

Neuronal ceroid lipofuscinosis

Trigeminal neuralgia

CDKL5-deficiency disorder

Progressive supranuclear palsy

Moderate and severe traumatic brain injury

Inclusion body myositis

Atypical autism

Limb-girdle muscular dystrophy

Ataxia-telangiectasia

CLN7 disease

Kennedy disease

CLN6 disease

Distal spinal muscular atrophy type 3

Moyamoya disease

Atypical Rett syndrome

Early-onset Lafora body disease

Acute disseminated encephalomyelitis

Dravet syndrome

Huntington disease

Guillain-Barré syndrome

Infantile spasms syndrome

Pantothenate kinase-associated neurodegeneration

Epilepsy syndrome

Neurodegeneration with brain iron accumulation

Malignant hyperthermia of anesthesia

Complex regional pain syndrome

Idiopathic inflammatory myopathy

Allan-Herndon-Dudley syndrome

Idiopathic intracranial hypertension

Lafora disease

Acute transverse myelitis

Rare dystonia

STXBP1-related encephalopathy

X-linked centronuclear myopathy

Rasmussen subacute encephalitis

Polyneuropathy associated with IgM monoclonal gammopathy with anti-MAG

Alexander disease

Classic stiff person syndrome

Canavan disease

Juvenile myoclonic epilepsy

Dentatorubral pallidoluysian atrophy

Primary angiitis of the central nervous system

X-linked Charcot-Marie-Tooth disease type 6

Centronuclear myopathy

Bilirubin encephalopathy

PANDAS

Charcot-Marie-Tooth disease type 4

Posterior cortical atrophy

SYNGAP1-related developmental and epileptic encephalopathy

Spastic paraplegia type 7

Spinocerebellar ataxia type 6

X-linked Charcot-Marie-Tooth disease type 1

Idiopathic hypersomnia

Rare metabolic diseases

Mitochondrial disease

Hyperphenylalaninemia due to tetrahydrobiopterin deficiency

Gaucher disease type 1

Cystinosis

Mucopolysaccharidosis type 3

Sanfilippo syndrome type C

Hurler syndrome

Barth syndrome

Acute hepatic porphyria

Mucopolysaccharidosis type 4

Glycogen storage disease due to acid maltase deficiency

Fabry disease

Niemann-Pick disease type C

Gaucher disease

Disorder of bile acid synthesis

Mucopolysaccharidosis type 4A

Classic galactosemia

Autosomal erythropoietic protoporphyria

Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia

Fucosidosis

Sanfilippo syndrome type A

Acute intermittent porphyria

Mucopolysaccharidosis type 10

Phenylketonuria

Mucopolysaccharidosis type 2

Tay-Sachs disease

GM2 gangliosidosis

Propionic acidemia

Ornithine transcarbamylase deficiency

Sandhoff disease

GM1 gangliosidosis

Tyrosinemia type 1

Danon disease

Erythropoietic porphyria

Galactosemia

Alkaptonuria

Porphyria

Vitamin B12-unresponsive methylmalonic acidemia

Sanfilippo syndrome type B

Farber disease

Mucopolysaccharidosis type 7

Galactosialidosis

Citrullinemia type I

Vitamin B12-responsive methylmalonic acidemia

Sialidosis

Congenital erythropoietic porphyria

Leigh syndrome

Krabbe disease

Citrullinemia

Mucopolysaccharidosis type 1

X-linked adrenoleukodystrophy

Lysosomal acid lipase deficiency

Mucopolysaccharidosis type 6

Mucolipidosis

Glycogen storage disease due to glycogen debranching enzyme deficiency

Homocystinuria due to cystathionine beta-synthase deficiency

Argininemia

Maple syrup urine disease

Mitochondrial trifunctional protein deficiency

Very long chain acyl-CoA dehydrogenase deficiency

Sanfilippo syndrome type D

PMM2-CDG

Alpha-mannosidosis

Glycogen storage disease due to glucose-6-phosphatase deficiency

Mitochondrial neurogastrointestinal encephalomyopathy

Wolman disease

Beta-mannosidosis

Argininosuccinic aciduria

Mitochondrial DNA-associated Leigh syndrome

GM3 synthase deficiency

Vitamin B12-unresponsive methylmalonic acidemia type mut0

Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C

Disorder of asparagine metabolism

Infantile neurovisceral acid sphingomyelinase deficiency

Rare oncological diseases

B-cell non-Hodgkin lymphoma

Rhabdoid tumor

Anaplastic thyroid carcinoma

Myeloproliferative neoplasm

Burkitt lymphoma

Malignant tumor of penis

Rare tumor of pancreas

Medulloblastoma

Adrenocortical carcinoma

Chondrosarcoma

Uveal melanoma

Malignant peripheral nerve sheath tumor

Von Hippel-Lindau disease

Primary cutaneous lymphoma

Systemic mastocytosis

Adenocarcinoma of the esophagus

Rare thyroid carcinoma

Malignant tumor of fallopian tubes

Chordoma

Adult T-cell leukemia/lymphoma

Gastroenteropancreatic neuroendocrine neoplasm

Cutaneous neuroendocrine carcinoma

Extranodal nasal NK/T cell lymphoma

Hepatoblastoma

Pseudomyxoma peritonei

Squamous cell carcinoma of the oral cavity

Diffuse intrinsic pontine glioma

Primary peritoneal carcinoma

Myelodysplastic neoplasm with increased blasts

Precursor T-cell acute lymphoblastic leukemia

Soft tissue sarcoma

Mantle cell lymphoma

Precursor B-cell acute lymphoblastic leukemia

Indolent B-cell non-Hodgkin lymphoma

Angioimmunoblastic T-cell lymphoma

Classic Hodgkin lymphoma

Medullary thyroid carcinoma

Waldenström macroglobulinemia

Anaplastic large cell lymphoma

Giant cell tumor of bone

Squamous cell carcinoma of the oropharynx

Classic mycosis fungoides

Squamous cell carcinoma of the anal canal

Central nervous system embryonal tumor

Carcinoma of the ampulla of Vater

Classic hairy cell leukemia

Ileal neuroendocrine tumor

Marginal zone lymphoma

Follicular lymphoma

Chronic myelomonocytic leukemia

Adenocarcinoma of ovary

Inflammatory myofibroblastic tumor

Benign schwannoma

Adult hepatocellular carcinoma

Skeletal Ewing sarcoma

Juvenile myelomonocytic leukemia

T-cell prolymphocytic leukemia

B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality

Carcinoma of the anal canal

Large granular lymphocyte leukemia

Benign tumor of fallopian tubes

Extramammary Paget disease

Hemangioblastoma

Yolk sac tumor

Germ cell tumor of testis

Plasmablastic lymphoma

Vulvar squamous cell carcinoma

Therapy related acute myeloid leukemia and myelodysplastic syndrome

Bronchial neuroendocrine tumor

Jejunal neuroendocrine tumor

Myelodysplastic neoplasm with increased blasts type 2

Mastocytosis

Rare genetic diseases

Rare urogenital diseases

Rare odontologic diseases

Rare gynecologic or obstetric diseases

Rare infertility

Rare abdominal surgical diseases

Rare maxillo-facial surgical disease

Rare disorder due to toxic effects

Rare surgical thoracic diseases

Rare surgical cardiac diseases

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.